Adjuvant chemotherapy for T3 prostate cancer: not ready for prime time.
Carducci
M A
MA
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D015996:Survival Rate
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D017430:Prostate-Specific Antigen